| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
Melanotransferrin, encoded by the MELTF gene and also designated as CD228, represents a fascinating member of the transferrin family with distinctive membrane-anchored properties. Originally identified as melanoma-associated antigen p97, this glycoprotein has garnered significant research interest due to its elevated expression in melanoma cells and its potential roles in iron metabolism, cell proliferation, and tumor progression. Understanding MELTF biology has become increasingly relevant for researchers investigating cancer biomarkers, iron homeostasis, and therapeutic targeting strategies.
This recombinant monoclonal antibody against human MELTF offers the reproducibility and consistency that demanding research applications require. Developed using recombinant technology with clone 4A11, this antibody provides a sequence-defined reagent that eliminates the lot-to-lot variability often encountered with traditional hybridoma-derived antibodies. The human IgG1 isotype format and affinity chromatography purification ensure high purity suitable for sensitive detection methods.
Validation studies demonstrate excellent binding characteristics in ELISA applications, with the antibody recognizing immobilized human MELTF protein at concentrations as low as the sub-nanogram range. Functional ELISA testing revealed an EC50 between 0.3476 and 0.4529 ng/mL, indicating strong binding affinity that supports reliable detection even at high dilutions ranging from 1:5000 to 1:50000.
Supplied in a liquid format containing PBS with glycerol for stability, this antibody is ready for immediate use in your experimental workflows. For researchers investigating melanoma biology, transferrin family proteins, or developing diagnostic approaches targeting CD228, this recombinant antibody provides a dependable tool for quantitative ELISA-based detection of human MELTF.
Email: support@cusabio.com
Distributors Worldwide